|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||32.61 - 32.83|
|52 Week Range||25.55 - 35.60|
|PE Ratio (TTM)||21.43|
|Dividend & Yield||0.90 (2.77%)|
|1y Target Est||N/A|
On the hunt for a fat dividend yield? These three big pharma stocks deliver.
There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca's lung cancer study data was positive and so was Bristol-Myers's melanoma candidate.
AstraZeneca (AZN) recently sold its remaining rights to its anaesthetics medicines to Aspen Group for an upfront consideration of $555 million.